Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Science.bio is a specialized e-commerce supplier of high-purity reference materials and research compounds for the life sciences community. The company focuses on providing a wide range of products including selective androgen receptor modulators (SARMs), nootropics, metabolic research compounds, and botanical extracts. Originally operating as IRC.bio, the firm rebranded to Science.bio and has established a reputation for rigorous third-party analytical testing and quality control. While their products are marketed strictly for laboratory research and not for human consumption, they serve a global market of independent researchers and academic institutions. The company is recognized for its transparency, providing publicly accessible certificates of analysis for every product batch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Science.bio.